Author:
Acosta Felquer Maria Laura,Coates Laura C.,Soriano Enrique R.,Ranza Roberto,Espinoza Luis R.,Helliwell Philip S.,FitzGerald Oliver,McHugh Neil,Roussou Euthalia,Mease Philip J.
Abstract
In 2009, GRAPPA published their first evidence-based recommendations for the treatment of psoriasis and psoriatic arthritis (PsA). Since then, new information has been published and drugs developed. We summarize evidence for the efficacy of available treatments for peripheral joint involvement in PsA. We performed a systematic review of current literature on the efficacy of different therapies, management, and therapeutic strategies for peripheral arthritis involvement in PsA, in order to provide information for the development of the new GRAPPA treatment recommendations.
Publisher
The Journal of Rheumatology
Subject
Immunology,Immunology and Allergy,Rheumatology
Reference71 articles.
1. The role of NSAIDs in psoriatic arthritis: Evidence from a controlled study with nimesulide;Sarzi-Puttini;Clin Exp Rheumatol,2001
2. A Comparison of the Efficacy and Safety of Celecoxib 200 mg and Celecoxib 400 mg Once Daily in Treating the Signs and Symptoms of Psoriatic Arthritis
3. Clinical phenotype of patients with arthritis mutilans has important differences compared to other patients with psoriatic arthritis;Haroon;Arthritis Rheum,2013
4. GENERALIZED PUSTULAR PSORIASIS.
5. Generalized pustular psoriasis induced by systemic glucocorticosteroids: four cases and recommendations for treatment
Cited by
52 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献